Novozymes Total Long Term Liabilities 2011-2023 | NVZMY

Novozymes total long term liabilities for the quarter ending December 31, 2023 were $0.984B, a 2.33% increase year-over-year.

  • Novozymes total long term liabilities for 2023 were $0.984B, a 2.33% increase from 2022.
  • Novozymes total long term liabilities for 2022 were $0.962B, a 12.24% decline from 2021.
  • Novozymes total long term liabilities for 2021 were $1.096B, a 40.12% increase from 2020.

Novozymes Total Long Term Liabilities 2011-2023 | NVZMY

  • Novozymes total long term liabilities for 2023 were $0.984B, a 2.33% increase from 2022.
  • Novozymes total long term liabilities for 2022 were $0.962B, a 12.24% decline from 2021.
  • Novozymes total long term liabilities for 2021 were $1.096B, a 40.12% increase from 2020.
Related Stocks
Company NameMarket
Cap
Linde (LIN)$216.5B
Sherwin-Williams (SHW)$97.8B
Ecolab (ECL)$69.5B
PPG Industries (PPG)$28.5B
International Flavors & Fragrances (IFF)$23.2B
Axalta Coating Systems (AXTA)$8.8B
Celanese (CE)$8.2B
CSW Industrials (CSWI)$7.2B
Element Solutions (ESI)$7B
Balchem (BCPC)$5.9B
Arcadium Lithium (ALTM)$5.7B
NewMarket (NEU)$5.2B
Nissan Chemical (NNCHY)$5.2B
Valvoline (VVV)$5B
H B Fuller (FUL)$4.2B
Ashland (ASH)$3.7B
Sensient Technologies (SXT)$3.3B
Quaker Houghton (KWR)$2.9B
Hawkins (HWKN)$2.7B
Minerals Technologies (MTX)$2.7B
Perimeter Solutions, SA (PRM)$1.9B
Ingevity (NGVT)$1.8B
Orbia Advance, S.A.B De C.V (MXCHY)$1.6B
ELEMENTIS (ELMTY)$1.3B
DAQO New Energy (DQ)$1.2B
Orion S.A (OEC)$1B
Huabao Holdings (HUIHY)$943M
AdvanSix (ASIX)$847M
Westlake Chemical Partners LP (WLKP)$824M
Green Plains (GPRE)$732M